Our divisions individually support and facilitate research for new treatments and cures in their respective areas of research. Visit their sites to learn more about clinical trial opportunities.
Clinical Trials by Division
Clinical Pharmacology is the study of drugs in humans. Current clinical trials in pharmacology include a gene therapy study with the University of Pennsylvania, a collaboration with the KU Alzheimer's Disease Center on EECP, exploration of a new class of drug inhibiting the PCSK9 protein, and a study to detect changes in COQ10 levels in patients taking statin therapy.
Gastroenterology & Hepatology clinical trials encompass a broad range of investigators and research topics. Within the division, our main areas of research include liver diseases, gastrointestinal motility disorder and pancreatic disease.
Infectious Disease remains dedicated to advancing scientific progress and innovation. Founded in 1958, our division's current research focuses on the areas of antimicrobial therapeutics, device discovery, public and global health, diagnostic testing and mentorship.
Nephrology & Hypertension clinical trials are currently taking place in regard to the subjects of investigational medications, PKD/ADPKD, cognitive impairment and functions and Fabry disease and its management.
Medical Oncology clinical trials support and facilitate research for new treatments and cures. Our investigators develop Phase II and III cooperative group clinical trials. View these at Cancer Site Specific Diseases and University of Kansas Cancer Center Clinical Trials.
Physical Activity and Weight Management clinical trials focus on the prevention of overweight and obesity across the lifespan.
Pulmonary, Critical Care and Sleep Medicine clinical trials focus on understanding the origins of asthma, how to decrease asthma morbidity and mortality, and testing of new biologics for precision-based individualized medicine.